Literature DB >> 16181478

Successful treatment with oral isotretinoin of acneiform skin lesions associated with cetuximab therapy.

R Gutzmer, T Werfel, R Mao, A Kapp, J Elsner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16181478     DOI： 10.1111/j.1365-2133.2005.06835.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  10 in total

1.  [Cutaneous side effects of EGF-receptor inhibition and their management].

Authors:  R Gutzmer; T Werfel; A Kapp; J Elsner
Journal:  Hautarzt       Date:  2006-06       Impact factor: 0.751

2.  [Cutaneous side effects of medical tumor therapy].

Authors:  A Degen; M Alter; F Schenck; A Kapp; R Gutzmer
Journal:  Hautarzt       Date:  2011-06       Impact factor: 0.751

Review 3.  Folliculitis induced by EGFR inhibitors, preventive and curative efficacy of tetracyclines in the management and incidence rates according to the type of EGFR inhibitor administered: a systematic literature review.

Authors:  Jean-Baptiste Bachet; Lucie Peuvrel; Claude Bachmeyer; Ziad Reguiai; Pierre A Gourraud; Olivier Bouché; Marc Ychou; Rene J Bensadoun; Brigitte Dreno; Thierry André
Journal:  Oncologist       Date:  2012-03-16

4.  Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients.

Authors:  Peter Arne Gerber; Stephan Meller; Tatiana Eames; Bettina Alexandra Buhren; Holger Schrumpf; Sonja Hetzer; Laura Maximiliane Ehmann; Wilfried Budach; Edwin Bölke; Christiane Matuschek; Andreas Wollenberg; Bernhard Homey
Journal:  Eur J Med Res       Date:  2012-02-23       Impact factor: 2.175

5.  [Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid, topical antibiotic and topical corticosteroid].

Authors:  A Wollenberg; N Moosmann; J Kroth; V Heinemann; E Klein
Journal:  Hautarzt       Date:  2007-07       Impact factor: 0.751

Review 6.  Skin problems and EGFR-tyrosine kinase inhibitor.

Authors:  Toshiyuki Kozuki
Journal:  Jpn J Clin Oncol       Date:  2016-01-29       Impact factor: 3.019

7.  Successful treatment of epidermal growth factor receptor inhibitor-induced periungual inflammation with adapalene.

Authors:  Junichi Hachisuka; Kazuko Doi; Yoichi Moroi; Masutaka Furue
Journal:  Case Rep Dermatol       Date:  2011-06-30

Review 8.  Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.

Authors:  Mario E Lacouture; Milan J Anadkat; René-Jean Bensadoun; Jane Bryce; Alexandre Chan; Joel B Epstein; Beth Eaby-Sandy; Barbara A Murphy
Journal:  Support Care Cancer       Date:  2011-06-01       Impact factor: 3.603

9.  Genetic Predictors of Severe Skin Toxicity in Patients with Stage III Colon Cancer Treated with Cetuximab: NCCTG N0147 (Alliance).

Authors:  Julia D Labadie; Xinwei Hua; Tabitha A Harrison; Barbara L Banbury; Jeroen R Huyghe; Wei Sun; Qian Shi; Greg Yothers; Steven R Alberts; Frank A Sinicrope; Richard M Goldberg; Thomas J George; Kathryn L Penney; Amanda I Phipps; Stacey A Cohen; Ulrike Peters; Andrew T Chan; Polly A Newcomb
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-11-17       Impact factor: 4.090

Review 10.  Epidermal growth factor receptor inhibitors: a review of cutaneous adverse events and management.

Authors:  K Chanprapaph; V Vachiramon; P Rattanakaemakorn
Journal:  Dermatol Res Pract       Date:  2014-03-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.